Stephen Quake - 01 Dec 2025 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Director
Signature: Tryn Stimart, attorney-in-fact
Issuer symbol: ABCL
Transactions as of: 01 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 19 Dec 2025, 14:46:13 UTC
Previous filing: 19 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Quake Stephen	Director	ABCELLERA BIOLOGICS INC, 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, CANADA	Tryn Stimart, attorney-in-fact	19 Dec 2025	0001685889

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share option (right to buy)	Award	$0	+194,932		$0.000000	194,932	01 Dec 2025	Common Shares	194,932	$3.47	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on December 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.